Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed.
It was a busy week with lots of news, have a look and see you next week for another update.
PharmaTher Provides Business Highlights and Releases Annual Financials
The company released business highlights and financial results for its fiscal year ended May 31, 2021. Read more
Psyched Wellness Commences Neurobehavioral Preclinical Trial Study
“This preclinical trial study moves the Company closer to being able to market our products in 2022 which are aimed at helping relaxation, stress relief, and better sleep.” Read more
Ketamine One Signs LOI for Two Ketamine Infusion Clinics in Texas
The arrangement bolsters the company’s proposed network of six clinics in the United States. Read more
Filament Health Shares to Commence Trading on the OTC Market
The company announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on the OTC Pink Market (the “OTC”) in the United States under the symbol “FLHLF”. Read more
Field Trip has just announced that the lead indications for FT-104 will be Treatment-Resistant Depression (TRD) and Postpartum Depression (PPD). Important mental health issues with big market potential. Read more
Novamind Uplists to OTCQB Venture Market
Novamind announced that its common shares have been approved for trading under the ticker symbol “NVMDF” on the OTCQB® Venture Market. Read more